The Cancer Biomarkers Research Group promotes research to identify, develop, and validate biological markers for early cancer detection and cancer risk assessment. Activities include development and validation of promising cancer biomarkers, collaborative databases and informatics systems, and new technologies or the refinement of existing technologies.
Read more About the Cancer Biomarkers Research Group.
Pancreatic Cancer Detection Consortium Steering Committee Meeting: A Tribute to Dr. Gloria Peterson
Date Posted: June 14, 2023
Speaker(s): Ann Oberg, Ph.D.; Suresh Chari, M.D.; Sudhir Srivastava, Ph.D., M.P.H.; Michael Goggins, M.D.; Lynn Matrisian, Ph.D., M.B.A.; Alison Klein, Ph.D., M.H.S.; Marian Pasca di Magliano, Ph.D.; Peter Allen, M.D.
Sponsor(s): NCI Division of Cancer Prevention, Cancer Biomarkers Research Group
This is an open workshop and free to attend. Registration is required.
News and Events
The Search for Early Detection of Pancreatic Cancer Accelerates with Biomarkers
Date Posted: April 27, 2021
Taking Advantage of the Transportation Processes from Inside to Outside the Cell to Detect Cancer
Date Posted: December 11, 2019
New Onset Diabetes Cohort Sought to Unravel Complexities of Pancreatic Cancer Development
Date Posted: November 19, 2019